Ekso Bionics (EKSO) Misses Q2 EPS by 116c

Ekso Bionics (NASDAQ: EKSO) reported Q2 EPS of ($1.24), $1.16 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $2.06 million versus the consensus estimate of $5.51 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.

You May Also Be Interested In

• Uniti Group (UNIT) 3700 contracts of July 13 calls trade, share up 7%
• Honeywell sees "a ton of opportunity for M&A," eyes $2B-$4B deals
• Active options: GOOGL SMCI META HOOD PLTR MSTR MRVL AMD NFLX SOFI SPCE AVGO